Investor
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
GOT A GOODIE Taking Position in PDGO
http://finance.yahoo.com/news/paradigm-oil-gas-weekly-oil-145000879.html
"Based on the current scenario of oil production, the Company forecasts nearly four million dollars in annual revenue. Analysts are expecting a breakout for Paradigm's stock if current levels of oil production and revenue continue. "Paradigm anticipates filing its audited 2013 and 2014 first quarter in early July and that will prove to the shareholders that we do not belong as a penny stock," stated Vince Vellardita."
Taking Position PDGO
http://finance.yahoo.com/news/paradigm-oil-gas-weekly-oil-145000879.html
"Based on the current scenario of oil production, the Company forecasts nearly four million dollars in annual revenue. Analysts are expecting a breakout for Paradigm's stock if current levels of oil production and revenue continue. "Paradigm anticipates filing its audited 2013 and 2014 first quarter in early July and that will prove to the shareholders that we do not belong as a penny stock," stated Vince Vellardita."
also $VNTH
Taking Position
http://finance.yahoo.com/news/paradigm-oil-gas-weekly-oil-145000879.html
"Based on the current scenario of oil production, the Company forecasts nearly four million dollars in annual revenue. Analysts are expecting a breakout for Paradigm's stock if current levels of oil production and revenue continue. "Paradigm anticipates filing its audited 2013 and 2014 first quarter in early July and that will prove to the shareholders that we do not belong as a penny stock," stated Vince Vellardita."
VNTH take a look. look at chart. read sec filings, read press releases.
http://finance.yahoo.com/q?s=VNTH
http://www.vantagehealthinc.com/#!vantage-in-the-news/c15u8
Looks like .25 is the new support! The number to break is .35 nice hold on up move
Not sure about app. But the clinicals are per pr due to happen this year and if the clinicals work that will be a bigggg deal!
Investors do your research! Vnth technology won invention of the year! And this ceo had partnerships he ran with such companies a ge and built a company into billion+ market cap with revenues in excess of 500 mil and a stock price of $50 he did it before looks like he is determine to do it again! Ok when we were trading at .10 - .15 range who sold?
What i see last few days is some serious buying! Guess we are being figured out! And looking foward to clinicals this year!!
Paulness the real shot here is VNTH lets stick to the press releases articles and mhealth and nasa technology because if we all stick to digging up info vnth good be a mega shot! He had a company once before went from pennies to i think over $50 dollars with partners like GE and other high end companies hoping the same here unlike under companies you hsve i think float of 25 mil a/s of 250 mil which management owns and doesnt appear to be sellers so if he succedes in clinicals my opinion we could end up on a higher exchang in the dollars with major partnerships sooner than later the pr stated clinicals this year, year is 1/2 over! And since non invasive i understand clinicals to take several months not years like most clinicals! The information on how the technology vnth holds is out thier! It also WON invention of the year! That should speak volumn! Just my opinion as everyone says regardless of buys or sells if this proves to work! Goes into the multi dollar range i would believe and imagine again opinion
$21+ were comming for you! As citigroup in report stated undiscovered! In it to win it!!!!
$ampe
$vnth
$healthcare
$pennystocks
$stocks
$mhealth
$citibank
My opinion when clinicals validate the sensors detect cancer thru your breath the potential in my opinion enormous! Just my opinion in it to win it
Higher lows - Higher highs new all time high today yahooooooo
Amazing volumn!!!
.32 offer
Who ever is buying is taking everyone out! Guess they are betting that the clinicals once they take place they will prove to be the disruptor in diagnosis of cancer - my opinion now!!!
Here we go again upward n onward
To all no pumping needed! NASA technology that won invention of the year! Vnth has agreement to bring to market per pr later this year is clinicals and its non invasive which to my understand is months to confirm soo if validated pumpers go away no need it will blow on its own in my opinion of course i do not recommend buy/sell or hold just you avg investor sharing what the pr and 10q's show
I would speculate with all the merger and aquistions in pharma a blood diagnostic firm would love to have a breath diagnostic technology! Just makes business sense just my common sense! Yahooooo
Q. What would a technology that diagnosis cancer thru your breath be worth among other diseases??
Most know that if clinicals work out you are holding a god knows how many dollar stock price this is big technology with major applucations in disease detection!!! Its like will wonka a golden ticket that can change lives on all fronta just my opinion i may be wring but my .24 cent opnion good luck to all
Vantage Health, Inc. is developing such a device, the Vantage Health Sensor, with clinical trials planned for later this year. To view the articles please click on the following links:
http://www.vantagehealthinc.com/#!Vantage-Health-Cited-In-The-Atlantic--A-Breathalyzer-That-Can-Diagnose-Cancer/cjnb/hv8n90ga1
Vantage Health, Inc., founded in 2010, based in Redwood City, CA, is a leading mobile health technology company – developing point-of-care screening using Apps based upon chemical sensing residing within a small Blue tooth enabled device that works with any smartphone called the Vantage Health Sensor.
With its foundations in advanced nanotechnology, the Company’s first product, the Vantage Health Sensor, is the convergence of nano-electronics, bio-informatics, and wireless technology to create the next generation mobile health application.
Vantage Health is developing the solution to saving lives and reducing healthcare costs through early detection and early disease screening. Early screening = higher survival rates and lower cost to patient and insurer.
The Company plans to market the Vantage Health Sensor device to Healthcare Providers (HCP) through domestic and international distributors.
INVESTMENT HIGHLIGHTS
NASA Invention of the Year 2012.
NASA grants five-year exclusive worldwide license to Vantage Inc. for IP associated with all patents issued and pending for commercialization in areas of healthcare and narcotics.
Strategic Partnership for Mobile Health Technology with Scripps Translational Science Institute is announced.
FDA clinical trial and commercialization for the Lung Cancer App launch within 18 months.
Total Addressable Market for lung cancer (four main global regions) for one year is $2.7 Billion for HCP’s and consumers.
Marketing initially to HCP through strategic large pharmaceutical partners. Business model is subscription based with recurring revenue occurring after purchase of device and monthly $30 subscription fee per application.
Business model delivers value to all parties (HCPs, Pharmacy, Patients and Insurance Companies).
Ongoing research collaborations with NASA and the Scripps Translational Science Institute.
OUR TECHNOLOGY – THE VANTAGE HEALTH SENSOR
The Vantage Health Sensor was birthed by NASA by taking care of the astronauts in space, ensuring the quality of their air was free of carbon monoxide and other noxious gases. Our Chairman and CEO, before his life here at Vantage, was a rocket scientist himself and repurposed the device with other scientists on the sensor team, to read our breath signature to detect various diseases.
Everyone’s breath is composed of Volatile Organic Compounds and combinations of them form giving doctors indications of various illnesses that are present in our bodies.
The Vantage Health Sensor is designed to screen for these various combinations so the doctor can identify them before symptoms appear, such as a tumor that appears when patients have a CT scan, which means patients will have many more treatment options available.
The fact that this technology will be Bluetooth enabled means that the Vantage Health Sensor is small and compact and will work with any smartphone making the data collected in real-time and immediately available for analysis to doctor and patient.
The Vantage Health Sensor automatically self-flushes after each use so the HCP can use the sensor with different patients as well as use the same sensor for different disease screening applications.
THE UNMET NEED
There were more deaths in 2012 from Lung Cancer than from Prostate, Pancreas, Breast and Colon combined.
Only 15 percent of lung cancer cases are screened at an early stage.
The five-year survival rate for lung cancer is 52.6 percent for cases detected early or when the disease is still localized.
For tumors spread to other organs, late-stage, the five-year survival rate is only 3.5 percent and this is why over half of people with lung cancer die within one year of being diagnosed.
There is an opportunity for low cost non-invasive detection of this disease at its earliest stages when treatment options are many and varied and lives can be saved.
OUR SOLUTION TO THE UNMET NEED
Our Vision involves A Vantage Health Sensor for each HCP with the desire to screen for early indications of lung cancer.
We believe HCP and patients will find breath analysis attractive – non-invasive, painless, having no side effects and available at an extremely low cost.
Our goal is to, with a strategic partner(s), commercialize mobile breath sensor technologies, with initial screening for lung cancer, that enable HCP to better manage the health care continuum from managing illness to managing wellness.
Early, non-invasive, inexpensive cancer screening is the first step in reducing deaths and lowering healthcare costs.
Once the lung cancer application is launched in early 2015, Vantage will start work on the next applications in the pipeline related to, Colorectal, Breast, Ovarian, Prostate, Pancreatic Cancers and Diabetes.
RECENT NEWS
2/10/14 - Vantage Health and Scripps Translational Science Institute form Strategic Partnership for Mobile Health Technology
1/7/14 - Vantage Health Receives License after NASA and Nanobeak enter into Exclusive Five-Year Commercial License
Agreement
12/18/2013 - Dr. William S. Rees Former Deputy Under-Secretary of Defense is appointed to Vantage Health Board of Directors
http://www.vantagehealthinc.com/#!investors/c1zxm
In it to win it very interesting!! Press releases
Last few month accumulation looked like it took out traders as if the climicalas on the nasa technology vnth hold proves valid we are talking new way of detection cancer n diseaeses! Vnth mhealth disreputor i think that is biggggg a billion dollar industry and vnth a multi dollar stock again just my opinion!!!
AGREE. The higher we go the better off we are for a stronger company!! And easier it gets to move foward! In my opinion
Looks like the stock under .20 was all bought up in my opinion new range over .20 cant wait for clinicals to begin!!!
Looks like consilidation n shake out ok im not looking for a week!
A lil buying we get over .20 im hoping for some updates soon last pr said clinicals later this year we 1/2 into year gonna get exciting
Level 2 shows it too move to .25 in my opinion
Awsome uptrend plus i like that it looks all shareholders are in the green and per 10q progress underway the way i see it onward n upward!!! Anyone call the investor relations vnth has listed on pr
Ptcgolf if clinicals show that vnth has technology that can detect cancer and at a lower cost $4 may be too low! I don't think i even can speculate as to the value but detecting diseases thru your breath is so non invasive its a big disruptor in the industry and what gives me added optimism is the technology was used in space and NASA Scientist developed it not a hoe blow!! Good luck to all
I feel once clinicals showcase that the technology works that we got from nasa scientist which i heard it works in space we have in my opinion a billion dollar company! And for others who dont know look up share structure!!! Unlike most vnth share structure looks good in 10q with no debt n cash onhand
Vnth - mhealth is going to be the medical disruptor like the cell phones were in my opinion the easy to diagnosis diseases!!! And vnth posses the technology nasa scientist created.
Yep .20 are the roof to break looks like only 70k approx not much at all
I have to disagree if u can get cancer early enough detected he can save on treatment and type of treatment just my opinion
I LIKE THIS!
Independant Valuations of VNTH
WealthMakers target of $ .50 and a short squeeze valuation of $2.85
http://www.buyins.com/reports/vnth2-25-14.pdf
WEALTHMAKERS.COM Issues Report on Vantage Health
WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued a new research report today on Vantage Health, Inc.
(OTC: VNTH). The report highlights the short term bullish pattern that has emerged, the SqueezeTrigger Price of $0.095 and the projected short squeeze price target of $2.85 per share.
$VNTH
$pennystocks
$wealthmakers
$mhealth
$healthcare
$buyins
I said to myself VNTH is one of those I was not going to trade, because if this gets validated in clinicals it in my opinion is a multi $$$$ stock. we are talking cancer detection which is a win win all around. + the technology was not developed by a joe blow in a garage it was done by nasa scientist. potential is real. if you liquidated all and it works you may want to look for a tall bridge (just kidding). from all the pr's and articles and last 10Q things look like they progressed. im waiting and watching
http://www.vantagehealthinc.com/#!vantage-in-the-news/c15u8
SOLID move, im expecting major upward move once we start clinicals as I am under impression because non invasive is 3-6 months to get done most have to do studies for way longer. and if it gets is validation! yahoooooooooooooooooooooooooo
this is CANCER ( early detection ) CAN SAVE LIVES + REDUCE COSTS by early detection.
A Breathalyzer That Can Diagnose Cancer
https://www.yahoo.com/tech/a-breathalyzer-that-can-diagnose-cancer-85624950229.html
More Postings under Yahoo Finance on VNTH
http://finance.yahoo.com/mb/forumview/?&bn=20ad1399-4694-3701-987e-aa491b065c22
$pennystocks $VNTH $MHEALTH $healthcare
Like to see as im sure everyone would close over .20 and above :)
VNTH the Bagger looks like it is begun :)
http://finance.yahoo.com/q?s=vnth&ql=1
$VNTH $healthcare $medical $mhealth $pennystock $pennystocks